ADVANCED SOLID MALIGNANT TUMOR
Clinical trials for ADVANCED SOLID MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED SOLID MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on advanced cancers in early trial
Disease control Recruiting nowThis study tests a new treatment called MSLN CAR-T for people with advanced solid tumors that have not responded to standard care. The therapy uses a patient's own immune cells, modified in a lab to target a protein called MSLN found on tumor cells. Up to 20 adults will receive c…
Matched conditions: ADVANCED SOLID MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new therapy called NW-101C, which uses a patient's own immune cells (T cells) that have been genetically modified to recognize and attack cancer cells carrying a protein called PRAME. The study will enroll 24 adults with advanced solid tumors that h…
Matched conditions: ADVANCED SOLID MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Neowise Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC